CryoCor Plans Launch After Gaining Approval For Cryoablation System
This article was originally published in The Gray Sheet
Executive Summary
CryoCor plans to begin marketing its cryoablation system for atrial flutter over the next several months, the firm announced Aug. 2
You may also be interested in...
CryoCor Sees Opportunity With A-Fib Ablation Label; Do Physicians Agree?
CryoCor hopes its lead in the race to gain an atrial fibrillation indication for an ablation catheter will translate into a market advantage, but first it will need to change what it says are misperceptions among some physicians about the limitations of cryoenergy
CryoCor Sees Opportunity With A-Fib Ablation Label; Do Physicians Agree?
CryoCor hopes its lead in the race to gain an atrial fibrillation indication for an ablation catheter will translate into a market advantage, but first it will need to change what it says are misperceptions among some physicians about the limitations of cryoenergy
People In Brief
AMO promotion: Advanced Medical Optics adds "president" to the title of Chief Operating Officer Richard A. Meier Nov. 19 to reflect increasing management responsibility for the executive. James V. Mazzo shed the president title, but remains CEO and chairman of the eye care device firm. Meier has held the COO spot since February, but relinquished chief financial officer responsibilities in October to new hire Michael J. Lambert. At that time, Meier's management duties expanded to cover AMO's cataract/implant business and global customer service function in addition to his continued oversight of the eye care division and the company's global manufacturing and supply chain operations